nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—NME1—peripheral nervous system neoplasm	0.595	1	CbGaD
Adefovir Dipivoxil—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.154	0.567	CbGbCtD
Adefovir Dipivoxil—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.0716	0.265	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0454	0.168	CbGbCtD
Adefovir Dipivoxil—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00672	0.152	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00466	0.105	CbGpPWpGaD
Adefovir Dipivoxil—Tenofovir—NME1—peripheral nervous system neoplasm	0.00419	1	CrCbGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00359	0.0808	CbGpPWpGaD
Adefovir Dipivoxil—AK4—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00325	1	CbGdCrCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00272	0.0613	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00208	0.0469	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00171	0.0386	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00144	0.0325	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00143	0.0322	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.00108	0.0243	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000985	0.0222	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—peripheral nervous system neoplasm	0.000883	0.0199	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.000727	0.0164	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—peripheral nervous system neoplasm	0.000659	0.0149	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000557	0.0125	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.000551	0.0124	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.000507	0.0114	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—peripheral nervous system neoplasm	0.000496	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000441	0.00993	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—GNS—peripheral nervous system neoplasm	0.000439	0.0099	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000404	0.0091	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.000384	0.00866	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—peripheral nervous system neoplasm	0.000329	0.00742	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.000318	0.00717	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000305	0.00688	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00028	0.00631	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000273	0.00615	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000262	0.0059	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000238	0.00538	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—GNS—peripheral nervous system neoplasm	0.000236	0.00531	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000228	0.00513	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—peripheral nervous system neoplasm	0.000224	0.00506	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000218	0.00492	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000215	0.00484	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000212	0.00478	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—peripheral nervous system neoplasm	0.000202	0.00455	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GNS—peripheral nervous system neoplasm	0.000197	0.00444	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000189	0.00426	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NME1—peripheral nervous system neoplasm	0.000189	0.00426	CbGpPWpGaD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00229	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000188	0.00424	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000187	0.00228	CcSEcCtD
Adefovir Dipivoxil—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00228	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000187	0.00422	CbGpPWpGaD
Adefovir Dipivoxil—Bone pain—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00228	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000187	0.00228	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00227	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00226	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000185	0.00225	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000183	0.00223	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000183	0.00223	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000183	0.00222	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000183	0.00222	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000182	0.0041	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—COX2—peripheral nervous system neoplasm	0.000182	0.0041	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000181	0.00221	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000181	0.0022	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000181	0.0022	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000181	0.0022	CcSEcCtD
Adefovir Dipivoxil—Back pain—Vincristine—peripheral nervous system neoplasm	0.00018	0.0022	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00018	0.00219	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00018	0.00219	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00218	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000179	0.00404	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.00218	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000179	0.00218	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000178	0.00216	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000178	0.00216	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00214	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000173	0.00389	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000172	0.0021	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000172	0.00209	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000171	0.00209	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00017	0.00207	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00017	0.00207	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00017	0.00207	CcSEcCtD
Adefovir Dipivoxil—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00206	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.00203	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000166	0.00202	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000166	0.00202	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.00201	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.00199	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000162	0.00198	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00198	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00196	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000159	0.00193	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000157	0.00353	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000156	0.0019	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000155	0.00189	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.00189	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.00188	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000154	0.00347	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00187	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00185	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000151	0.00183	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00183	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000149	0.00182	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000149	0.00182	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000149	0.00182	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000149	0.00336	CbGpPWpGaD
Adefovir Dipivoxil—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000149	0.00181	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00181	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000149	0.00181	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000148	0.0018	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000148	0.0018	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000148	0.0018	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.00179	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000147	0.00179	CcSEcCtD
Adefovir Dipivoxil—Back pain—Etoposide—peripheral nervous system neoplasm	0.000146	0.00178	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000145	0.00177	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000145	0.00177	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00176	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.00175	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000144	0.00175	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000143	0.00323	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—ENO2—peripheral nervous system neoplasm	0.000143	0.00322	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000143	0.00174	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.00174	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000142	0.00319	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000141	0.00171	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00014	0.00171	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.00014	0.00315	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00014	0.0017	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000139	0.0017	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000139	0.0017	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.00169	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000139	0.00169	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.00167	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GNS—peripheral nervous system neoplasm	0.000137	0.00308	CbGpPWpGaD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00166	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.00166	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.00164	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.00164	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000134	0.00163	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Rash—Topotecan—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000132	0.00161	CcSEcCtD
Adefovir Dipivoxil—Cough—Etoposide—peripheral nervous system neoplasm	0.000132	0.0016	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000132	0.0016	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000132	0.0016	CcSEcCtD
Adefovir Dipivoxil—Headache—Topotecan—peripheral nervous system neoplasm	0.000132	0.0016	CcSEcCtD
Adefovir Dipivoxil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000131	0.0016	CcSEcCtD
Adefovir Dipivoxil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.0016	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000131	0.0016	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000131	0.0016	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.0016	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—NME1—peripheral nervous system neoplasm	0.000131	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000131	0.00159	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00159	CcSEcCtD
Adefovir Dipivoxil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00013	0.00159	CcSEcCtD
Adefovir Dipivoxil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00013	0.00159	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00158	CcSEcCtD
Adefovir Dipivoxil—Rash—Melphalan—peripheral nervous system neoplasm	0.00013	0.00158	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00013	0.00158	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.00157	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000129	0.00157	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00156	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000128	0.00155	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000126	0.00284	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—COX2—peripheral nervous system neoplasm	0.000126	0.00284	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00152	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00152	CcSEcCtD
Adefovir Dipivoxil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000125	0.00152	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000124	0.00151	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00151	CcSEcCtD
Adefovir Dipivoxil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000124	0.00151	CcSEcCtD
Adefovir Dipivoxil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000124	0.00151	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000123	0.00149	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.00149	CcSEcCtD
Adefovir Dipivoxil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000122	0.00149	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00148	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000121	0.00147	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00012	0.00146	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00012	0.00146	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.00012	0.00271	CbGpPWpGaD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00146	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00012	0.00146	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000119	0.00269	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00145	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000117	0.00143	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000117	0.00142	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000116	0.00142	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000116	0.00141	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—SLC2A1—peripheral nervous system neoplasm	0.000115	0.00259	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.0014	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000115	0.00258	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00138	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.00136	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00011	0.00248	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00134	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00134	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000109	0.00133	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000109	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000108	0.00132	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.00132	CcSEcCtD
Adefovir Dipivoxil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000107	0.0013	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000107	0.0024	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000106	0.0013	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000106	0.0013	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00129	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00129	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GNS—peripheral nervous system neoplasm	0.000104	0.00233	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00126	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00125	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00124	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00124	CcSEcCtD
Adefovir Dipivoxil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.00123	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000101	0.00228	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000101	0.00123	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.00122	CcSEcCtD
Adefovir Dipivoxil—Rash—Alitretinoin—peripheral nervous system neoplasm	9.95e-05	0.00121	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.94e-05	0.00121	CcSEcCtD
Adefovir Dipivoxil—Headache—Alitretinoin—peripheral nervous system neoplasm	9.89e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.00119	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.00119	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.00119	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.67e-05	0.00218	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Vincristine—peripheral nervous system neoplasm	9.67e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.65e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.63e-05	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Rash—Vincristine—peripheral nervous system neoplasm	9.59e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.58e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—COX2—peripheral nervous system neoplasm	9.56e-05	0.00215	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Headache—Vincristine—peripheral nervous system neoplasm	9.53e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TH—peripheral nervous system neoplasm	9.49e-05	0.00214	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.00115	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.38e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.2e-05	0.00207	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.2e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.19e-05	0.00207	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Vincristine—peripheral nervous system neoplasm	9.04e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.00109	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Etoposide—peripheral nervous system neoplasm	8.84e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.84e-05	0.00199	CbGpPWpGaD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.00107	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Etoposide—peripheral nervous system neoplasm	8.72e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.55e-05	0.00104	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.52e-05	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Cisplatin—peripheral nervous system neoplasm	8.48e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.43e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.33e-05	0.00188	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	8.3e-05	0.00187	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ENO2—peripheral nervous system neoplasm	8.28e-05	0.00187	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000997	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cisplatin—peripheral nervous system neoplasm	7.99e-05	0.000973	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.97e-05	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Etoposide—peripheral nervous system neoplasm	7.83e-05	0.000954	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000954	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000953	CcSEcCtD
Adefovir Dipivoxil—Rash—Etoposide—peripheral nervous system neoplasm	7.77e-05	0.000946	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000945	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GNAS—peripheral nervous system neoplasm	7.75e-05	0.00175	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.74e-05	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.00094	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.00094	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.64e-05	0.00172	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.6e-05	0.00171	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000922	CcSEcCtD
Adefovir Dipivoxil—Cough—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000899	CcSEcCtD
Adefovir Dipivoxil—Nausea—Etoposide—peripheral nervous system neoplasm	7.32e-05	0.000891	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000881	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000877	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000877	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000871	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—BCHE—peripheral nervous system neoplasm	7e-05	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.99e-05	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	6.94e-05	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.92e-05	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000832	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000825	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000823	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000817	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—GNS—peripheral nervous system neoplasm	6.68e-05	0.00151	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.67e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000812	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000812	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.65e-05	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000806	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000802	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—TH—peripheral nervous system neoplasm	6.58e-05	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.29e-05	0.000766	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—ENO2—peripheral nervous system neoplasm	6.27e-05	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000763	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000762	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000756	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.2e-05	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000742	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.00074	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000731	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000726	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.91e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.83e-05	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000709	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.000688	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000685	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—GNS—peripheral nervous system neoplasm	5.59e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000677	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000672	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000665	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000665	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GNAS—peripheral nervous system neoplasm	5.37e-05	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NME1—peripheral nervous system neoplasm	5.36e-05	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—BCHE—peripheral nervous system neoplasm	5.3e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.27e-05	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000636	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—COX2—peripheral nervous system neoplasm	5.16e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.06e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000615	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000615	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—TH—peripheral nervous system neoplasm	4.98e-05	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000603	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000595	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000575	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.69e-05	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.68e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP3R1—peripheral nervous system neoplasm	4.67e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.64e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.6e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000558	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000551	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNS—peripheral nervous system neoplasm	4.49e-05	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000535	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000532	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.00053	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.00053	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000527	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—NME1—peripheral nervous system neoplasm	4.3e-05	0.000969	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.3e-05	0.000968	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.22e-05	0.00095	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—COX2—peripheral nervous system neoplasm	4.14e-05	0.000933	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	4.13e-05	0.000932	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.0005	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GNAS—peripheral nervous system neoplasm	4.07e-05	0.000917	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000495	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	4.05e-05	0.000912	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.04e-05	0.000911	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000491	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000488	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.99e-05	0.0009	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000462	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.76e-05	0.000848	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.76e-05	0.000847	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.69e-05	0.000832	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	3.58e-05	0.000807	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.52e-05	0.000793	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.39e-05	0.000765	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	3.39e-05	0.000764	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.33e-05	0.00075	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	3.26e-05	0.000735	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.25e-05	0.000733	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.19e-05	0.000719	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	2.86e-05	0.000645	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.83e-05	0.000638	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.78e-05	0.000626	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.73e-05	0.000616	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO2—peripheral nervous system neoplasm	2.72e-05	0.000613	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	2.69e-05	0.000607	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.61e-05	0.000589	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	2.3e-05	0.000518	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	2.2e-05	0.000495	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.19e-05	0.000494	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	2.16e-05	0.000487	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.000486	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—peripheral nervous system neoplasm	2.09e-05	0.000471	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.97e-05	0.000443	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	1.82e-05	0.000411	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000397	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.73e-05	0.00039	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.57e-05	0.000354	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000327	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	1.44e-05	0.000325	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.2e-05	0.000271	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000259	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000248	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—peripheral nervous system neoplasm	1.02e-05	0.00023	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	8.02e-06	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	7.08e-06	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	5.93e-06	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.76e-06	0.000107	CbGpPWpGaD
